An aptamer strategy to target oncogenic signaling in ErbB2 carrying human tumors.
Collaboration with:
G. Mahlknecht , Y. Yarden G. Mahlknecht
Synergy of antibodies towards decreasing pancreatic cancer.
Collaboration with:
R. Maron, B. Schechter, Y. Yarden
Towards vaccination: Generation of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.
Collaboration with:
E. Witsch, Y. Yarden
Mechanism of action of Copolymer 1 (Copaxone), a therapeutic vaccine against multiple sclerosis.
Collaboration with:
R. Arnon
Effective synergism by anti ErbB-2 mAb combinations comprising one mAb against the dimerization site of ErbB-2.
Collaboration with:
Y. Yarden
Monoclonal antibodies (mAbs) to ErbB-1 and ErbB-2 receptors and their role in potential anti-tumor strategy.
Collaboration with:
B. Schechter, Y. Yarden
Synergistic effects of combinations of mAb against distinct epitopes on EGFR/ErbB-1 and ErbB-2 receptors: accelerated receptor aggregation, down regulation and inhibition of tumor growth.
Collaboration with:
B. Schechter, Y. Yarden
